Bolt Biotherapeutics, Inc. (BOLT) vs Enveric Biosciences, Inc. (ENVB)
Bolt Biotherapeutics, Inc. and Enveric Biosciences, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Enveric Biosciences, Inc. are of similar size ($6.9M and $6.9M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against −13.9%. Enveric Biosciences, Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 17 metrics below, Enveric Biosciences, Inc. leads on 11 and Bolt Biotherapeutics, Inc. on 6.
Valuation
Profitability
| Metric | BOLT | ENVB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (654.53%) | 0.00% | 0.00% |
| Net margin | (611.47%) | 0.00% | 0.00% |
| Free cash flow margin | (655.72%) | 0.00% | 0.00% |
| Return on equity | (111.65%) | (235.48%) | (57.72%) |
| Return on assets | (49.62%) | (193.53%) | (49.22%) |
| Return on invested capital | (143.75%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack